8-K current report · filed Oct 19, 2026

Aquestive Therapeutics, Inc. (AQST) 8-K Current Report: October 19, 2026

Item 5.03AQST overview

Short answer

Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on October 19, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Board-adopted bylaws effective October 15, 2026, superseding prior bylaws.

Aquestive Therapeutics, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • Board-adopted bylaws effective October 15, 2026, superseding prior bylaws
  • Reduced disclosure requirements for stockholder board nominations
  • Removed certain “acting in concert” relationship disclosures involving nominees and associated persons
  • Potentially lowers procedural burden for shareholders proposing director candidates
  • Exhibit 3.1 contains controlling amended-bylaw language

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Aquestive Therapeutics, Inc. 8-K filings

Get the next AQST 8-K as it lands

Follow AQST for push alerts, or ask the research agent what this filing means.